Procyon Advisors’s Exelixis EXEL Stock Holding History

Procyon Advisors’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	–	–	459
2020 Q2	$0	Hold	9	–	–	﹤0.01%	1103
2020 Q1	$0	Hold	9	–	–	﹤0.01%	1046
2019 Q4	$0	Buy	+9	New	+$153	﹤0.01%	1014

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Procyon Advisors's EXEL Position: Q3 2020 in Review

Procyon Advisors sold out of Exelixis (EXEL) in Q3 2020, closing a stake of 9 shares.

Procyon Advisors first reported a position in EXEL in Q4 2019 and held it in 3 quarters. The position peaked at $0 in Q2 2020. 367 funds tracked by Wall St. Rank hold EXEL as of Q3 2020.

Procyon Advisors reported no remaining Exelixis position as of Q3 2020 after selling out during the quarter.
Procyon Advisors sold 9 Exelixis shares in Q3 2020.
Procyon Advisors first reported a position in Exelixis in Q4 2019 and held it in 3 quarters.
Procyon Advisors's Exelixis position peaked at $0 in Q2 2020.
367 funds tracked by Wall St. Rank held Exelixis as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.